ArticleClinical cancer research : an official journal of the American Association for Cancer Research2016
Correction: Preclinical Efficacy of the MDM2 Inhibitor RG7112 in MDM2-Amplified and TP53 Wild-type Glioblastomas.
No numbers read from the abstract.